SCHEMBL3790780

SCHEMBL3790780

CCn1nc(NC(=O)C2CCCCN2CC2CCOCC2)nc1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 10/20 0.51
CNR1 P21554 9/20 0.51
KCNK3 O14649 1/20 0.41
LMNA P02545 1/20 0.41
HSD11B1 P28845 2/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 1/20 0.39
KCNH2 Q12809 1/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
PDE8B O95263 1/20 0.37
POLB P06746 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
JAK1 P23458 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13256989 1.00 CNR2 (0.51) CNR2CNR1KCNK3LMNAHSD11B1
SCHEMBL13256997 0.86 CNR2 (0.48) CNR2CNR1KCNK3LMNAJAK1
SCHEMBL16239264 0.83 CNR1 (0.42) CNR2CNR1SMN1; SMN2
SCHEMBL16254983 0.81 CNR2 (0.52) CNR2CNR1KCNK3LMNAHSD11B1
SCHEMBL13256796 0.79 CNR2 (0.52) CNR2CNR1LMNAHSD11B1POLB
SCHEMBL13284561 0.79 CNR2 (0.52) CNR2CNR1KCNK3LMNAHSD11B1
SCHEMBL13257045 0.77 ALDH1A1 (0.58) CNR2CNR1HSD11B1POLBTSHR
SCHEMBL13257194 0.77 CNR2 (0.57) CNR2CNR1LMNAHSD11B1POLB
SCHEMBL13256788 0.76 SMN1; SMN2 (0.60) CNR2CNR1LMNASMN1; SMN2KDM4E
SCHEMBL3711811 0.76 MEN1 (0.54) CNR2LMNAJAK2POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398771-A2 HETEROCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2011-12-28 EP claimed
WO-2010096371-A2 HETEROCYCLIC COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-08-26 WO claimed